United States

Coloplast A/S (COLOb.CO)

COLOb.CO on Copenhagen Stock Exchange

9:45am EDT
Change (% chg)

kr.-2.50 (-0.49%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for COLOb.CO


Coloplast A/S is a Denmark-based company active within the healthcare sector. It is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for... (more)


Beta: 0.83
Market Cap(Mil.): kr.101,871.00
Shares Outstanding(Mil.): 198.00
Dividend: 4.50
Yield (%): 2.43


  COLOb.CO Industry Sector
P/E (TTM): 84.57 37.54 36.60
EPS (TTM): 6.08 -- --
ROI: 23.45 12.49 13.91
ROE: 25.20 14.81 14.82

BRIEF-Coloplast introduces new wound dressing as part of growth ambition

* Says Coloplast introduces new silicone wound dressings as part of growth ambition.

3:18am EDT

BRIEF-Kristian Villumsen sells and buys shares in Coloplast

* Kristian Villumsen, Executive Vice President, sold 60,000 shares in Coloplast at 504.08 Danish crowns ($76.24) per share

Sep 07 2016

UPDATE 1-Denmark's Coloplast to invest in UK despite Brexit -CFO

* "It's difficult to predict the outcome of Britain's negotiations with the EU but we will continue to invest in Britain," said Chief Financial Officer Anders Lonning-Skovgaard

Aug 16 2016

BRIEF-Coloplast Q3 EBIT DKK 1.20 billion, below estimates

* Q3 revenue 3.69 billion Danish crowns ($559.15 million) versus 3.72 billion crowns seen in Reuters poll

Aug 16 2016

Coloplast cuts growth forecast due to emerging markets challenges

COPENHAGEN, June 22 Danish healthcare products maker Coloplast on Wednesday adjusted its growth forecast downwards due to a challenging macroeconomic environment in emerging markets.

Jun 22 2016

BRIEF-Coloplast adjusts downwards 3-yr organic revenue growth outlook

* Says Board approved new long-term financial guidance, spanning three years

Jun 22 2016

EUROPE RESEARCH ROUNDUP-Luxottica, Bavarian Nordic, Elior

May 4 Securities analysts revised their ratings and price targets on several European companies, including D'Ieteren, NCC and Luxottica, on Wednesday. HIGHLIGHTS * NCC Group : Jefferies starts with buy rating * Elior Group : HSBC cuts to hold from buy * Bavarian Nordic : Cowen & Company starts with outperform rating * Luxottica Group : Raymond James raises to outperform rating * D'Ieteren SA : ING cu

May 04 2016

UPDATE 1-Coloplast hails UK growth but cuts outlook on weak pound

* Danish company has started to recover market share, says CFO

May 03 2016

RPT-Coloplast trims FY guidance due to lower currency exchange rates

COPENHAGEN, May 3 Danish healthcare product maker Coloplast posted second quarter sales and operating profit roughly in line with analysts' expectations, but trimmed its full-year sales growth forecast due to lower currency exchange rates.

May 03 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
Provider : Wright Reports
Provider : MarketLine
Provider : Thomson Reuters StreetEvents
Provider : GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.